Chemoinformaics analysis of Stigmastan-3,5-diene
Molecular Weight | 396.703 | nRot | 6 |
Heavy Atom Molecular Weight | 348.319 | nRig | 20 |
Exact Molecular Weight | 396.376 | nRing | 4 |
Solubility: LogS | -7.42 | nHRing | 0 |
Solubility: LogP | 8.305 | No. of Aliphatic Rings | 4 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 48 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 29 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 80.4361 |
nHD | 0 | BPOL | 48.1539 |
QED | 0.42 |
Synth | 4.507 |
Natural Product Likeliness | 2.786 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.925 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.924 |
MDCK | 0.00000481 |
BBB | 0.487 |
PPB | 0.992408 |
VDSS | 3.252 |
FU | 0.0126501 |
CYP1A2-inh | 0.056 |
CYP1A2-sub | 0.523 |
CYP2c19-inh | 0.106 |
CYP2c19-sub | 0.973 |
CYP2c9-inh | 0.106 |
CYP2c9-sub | 0.478 |
CYP2d6-inh | 0.019 |
CYP2d6-sub | 0.88 |
CYP3a4-inh | 0.344 |
CYP3a4-sub | 0.864 |
CL | 13.914 |
T12 | 0.017 |
hERG | 0.978 |
Ames | 0.012 |
ROA | 0.049 |
SkinSen | 0.975 |
Carcinogencity | 0.032 |
EI | 0.013 |
Respiratory | 0.726 |
NR-Aromatase | 0.047 |
Antiviral | No |
Prediction | 0.706737 |